全球一次性生物加工市场规模（按地区、范围和预测）

一次性生物加工市场规模及预测

2021 年一次性生物加工市场规模价值 110.5 亿美元，预计到 2030 年将达到 151 亿美元，2022 年至 2030 年的复合年增长率为 18.02%。生物製药需求不断增长、能源效率高、用水量低、占地面积小、产品交叉污染风险低以及实施速度快是一次性生物处理的一些关键优势。全球市场。全球对生物製药的需求正在快速成长。许多大公司正积极投资生物製药及其相关产品。推动需求成长的最大因素之一是老龄人口的成长和慢性病的流行。因此，预计全球一次性生物加工市场在整个预测期内将大幅成长。

定义全球一次性生物加工市场

多种生物处理技术均采用一次性培养基袋及容器。此外，生物製药和生物製造领域经常使用一次性容器来进行关键的液体处理应用。单株抗体（mAb）采用一次性生物加工技术製造，因此该领域在全球一次性生物加工市场中占据主导地位。由于一次性技术 (SUT) 带来的好处（包括显着减少资本成本和设施建设时间），生物加工中一次性产品的使用急剧增加。因此，一次性生物加工市场正在经历两位数的成长。

全球老年人口的成长可能会在未来几年推动市场扩张。根据联合国预测，到2050年，全球预计将有约15亿人口年龄在65岁或以上。人口老化容易促使慢性疾病，这可能会大幅增加对生物製药的需求和消费，从而刺激全球一次性生物加工市场的扩张。

一次性生物处理的全球市场概况

许多最终用户将一次性系统 (SUS) 视为实现最高水准生产力和流程效率的经济可行策略。因此，SUS 设备广泛应用于生物製造的各个阶段，尤其是在商业化前生物製药的生产中。这反过来又为该行业的产品提供者创造了商机。

影响一次性生物加工市场的关键趋势之一是，为生物製药的商业合成提供耐用一次性用品的供应商数量不断增加。大数据分析预计将成为主导趋势。透过实现预测和製程参数，采用基于大数据机器学习的分析模型可望提高产品产量。由于 SUT 在需要快速週转时间的多产品生物加工中易于使用且有效，CMO 现在看到一次性用品的采用率显着提高。一次性生物加工市场受到製药业日益增长的需求的严重影响。大多数生物製药公司扩大采用一次性生物加工系统，因为它们可以提高製程效率并降低钢製生物反应器的灭菌、清洁和维护成本。一次性生物处理系统用于各种生物製药应用，包括混合、过滤、净化和储存。生物製药产业也在快速扩张。生物製药约占全球医药市场的20%。

目录

第 1 章 全球一次性生物加工市场简介

市场概况
• 研究范围
• 先决条件

第 2 章执行摘要

第 3 章：经过验证的市场研究方法

• 资料探勘
• 验证
• 主要来源
• 资料来源列表

第 4 章全球一次性生物加工市场展望

• 概述
• 市场动态
  • 驱动程式
  • 阻碍因素
  • 机会
• 波特五力模型
• 价值链分析

第5章全球一次性生物加工市场（依产品划分）

• 概述
• 容器
• 媒体包

第6章全球一次性生物处理市场（按应用）

• 概述
• 上游
• 发酵
• 下游

第7章 全球一次性生物处理市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
  亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 世界其他地区
  • 拉丁美洲
  • 中东和非洲

第 8 章全球一次性生物加工市场：竞争格局

• 概述
• 各公司的市场排名
• 主要发展策略

第9章 公司简介

• Thermo Fisher Scientific, Inc.
• Merck KGaA
• Sartorius AG
• Corning Incorporated
• Pall Corporation
• General Electric Company（GE Healthcare）
• Eppendorf AG
• Lonza
• Meissner Filtration Products, Inc.
• JM BioConnect

第 10 章附录

• 相关报告

Single-Use Bioprocessing Market Size And Forecast

Single-Use Bioprocessing Market size was valued at USD 11.05 Billion in 2021 and is projected to reach USD 15.1 Billion by 2030, growing at a CAGR of 18.02% from 2022 to 2030. Increasing demand for biopharmaceuticals, high energy efficiency, low tide usage, less floor space requirement, very low risk of product cross-contamination, and faster to implement are the key drivers for the expansion of the global single-use bioprocessing market. The global demand for biopharmaceuticals is rapidly increasing. Many leading pharmaceutical companies are actively investing in biopharmaceuticals and related products. One of the most significant drivers of this demanding hike is the growing elderly population and the prevalence of chronic conditions. Hence, throughout the forecast period, the global single-use bioprocessing market is expected to grow significantly faster.

Global Single-Use Bioprocessing Market Definition

Various bioprocessing techniques employ single-use media bags and containers. Additionally, the biopharmaceutical and biomanufacturing sectors frequently employ single-use containers for crucial liquid handling applications. Monoclonal antibodies (mAb) are produced using single-use bioprocessing technologies; as a result, this sector dominates the global single-use bioprocessing market. The usage of disposables has increased dramatically in the bioprocessing sector as a result of benefits provided by single-use technology (SUT), such as a considerable decrease in capital cost and facility building time. The market for single-use bioprocessing has grown by double digits as a result of this.

The expanding elderly population throughout the globe is likely to boost the market expansion in the following years. According to the United Nations, by 2050, it is predicted that roughly 1.5 billion of the global population would be of or over the age of 65 years. The senior population is more susceptible to chronic illnesses, thus there will be a significant increase in demand and consumption of biopharmaceutical drugs, which will fuel the expansion of the global single-use bioprocessing market.

Global Single-Use Bioprocessing Market Overview

Many end-users view single-use systems (SUS) as an economically feasible strategy to attain the highest level of productivity and process efficiency. SUS equipment is therefore extensively used throughout the biomanufacturing phases, but especially in the production of pre-commercial biopharmaceuticals. Opportunities have been generated for the industry's product providers as a result.

One of the key trends influencing the market for single-use bioprocessing is the growing number of suppliers providing durable disposables for the commercial synthesis of biopharmaceuticals. Big data analytics is expected to be the dominant trend. By enabling prediction and process parameters, the adoption of analytical models based on big data machine learning is projected to increase product yields. Due to the simplicity of use and effectiveness of SUTs in the bioprocessing of several products needing quick turnaround times, CMOs are currently adopting disposables at a significantly greater rate. The market for single-use bioprocessing is heavily influenced by the pharmaceutical industry's expanding need. Because single-use bioprocessing systems can boost process efficiency and lower the expenses involved with sterilizing, cleaning, and maintaining steel bioreactors, the majority of biopharmaceutical businesses are progressively implementing this technology. The single-use bioprocessing system is employed in a variety of biopharmaceutical applications, including mixing, filtering, purification, and storage. The biopharmaceutical industry is also expanding quickly. About 20% of the global pharma market is made up entirely of biopharmaceuticals.

Global Single-Use Bioprocessing Market: Segmentation Analysis

The Global Single-Use Bioprocessing Market is segmented based on Product, Workflow, End Use, And Geography.

Single-Use Bioprocessing Market, By Product

• Containers
• Media bags

Based on the Product, the global single-use bioprocessing market is divided into media bags and containers. In the market, single-use containers are more popular than single-use media bags. During the forecast period, the trend is expected to continue, offering the containers segment a leading market share of the global single-use bioprocessing market.

Single-Use Bioprocessing Market, By Workflow

• Upstream
• Fermentation
• Downstream
• The market is divided into upstream, fermentation, and downstream segments based on workflow. The single-use bioprocessing market is predicted to expand owing to the introduction of a wide array of SUS to be utilized throughout various phases of biomanufacturing. A significant portion of upstream processing has been facilitated by the use of SUS for cell culture, liquid handling, and storage.

Single-Use Bioprocessing Market, By End Use

• Biopharmaceutical Manufacturer
• Academic & Clinical Research Institutes
• Others

Based on End Use, the market is bifurcated into Biopharmaceutical Manufacturer, Academic & Clinical Research Institutes, and Others. The biopharmaceutical manufacturing industry is expected to significantly benefit from the growing popularity of disposables among CMOS. Contract service providers are engaged in the expansion of single-use capacity by installing new Single-Use Bioprocessing products at their facility, thereby aiding in revenue regeneration.

Single-Use Bioprocessing Market, By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa
• North America, Europe, Asia Pacific, Latin America (LATAM), the Middle East and Africa are the five main geographic divisions covered in the global single-use bioprocessing market report. The market for single-use bioprocessing is being adopted as a result of the growing need for biopharmaceuticals as well as its benefits, which include quick deployment, minimal risk of product cross-contamination, high energy efficiency, and low water consumption.

Key Players

• The "Global Single-Use Bioprocessing Market" study report will provide valuable insight with an emphasis on the global market. The major players are
• Thermo Fisher Scientific, Merck, Sartorius, Corning Incorporated, Pall Corporation, General Electric, Eppendorf, Rentschler Biopharma, Lonza, Meissner Filtration Products Inc., JM BioConnect, etc.
• The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In March 2020: Danahar acquired the life sciences division of General Electric, Cytiva. Through this acquisition, Danahar is looking to expand its existing life sciences business and obtain a significant market share.
• In September 2020: As a step towards expanding its life science business, Thermo Fisher Scientific did an investment of over 475 million at its St. Louis plant. The investment is mainly focused on carrying out research and development activities in several fields such as gene therapies, drug development, biopharmaceuticals, and biologics.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL SINGLE USE BIOPROCESSING MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL SINGLE USE BIOPROCESSING MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL SINGLE USE BIOPROCESSING MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 Containers
• 5.3 Media bags

6 GLOBAL SINGLE USE BIOPROCESSING MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Upstream
• 6.3 Fermentation
• 6.4 Downstream

7 GLOBAL SINGLE USE BIOPROCESSING MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East and Africa

8 GLOBAL SINGLE USE BIOPROCESSING MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Thermo Fisher Scientific, Inc.
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Merck KGaA
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Sartorius AG
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Corning Incorporated
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Pall Corporation
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 General Electric Company (GE Healthcare)
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Development
• 9.7 Eppendorf AG
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Lonza
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Meissner Filtration Products, Inc.
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Development
• 9.10 JM BioConnect
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Development

10 Appendix

• 10.1.1 Related Reports